transdermal estrogen [horm, phsu, strd]
Therapy Effect [fndg]
fibrinogen levels [lbpr]
Women [popg]
past history [qlco]
Venous Thromboembolism [patf]
Pilot Study [resa]
Objective [inpr]
To [qlco]
Evaluate [ftcn]
Thromboelastography [lbpr]
Parameters [fndg]
fibrinogen levels [lbpr]
Women [popg]
treated [topp]
Transdermal [ftcn]
Methods [inpr]
Menopausal [phsf]
Women [popg]
History [ocdi]
Venous thromboembolic disease [patf]
included [ftcn]
Nine [qnco]
Patients [podg]
treatment [ftcn]
HT [geoa]
Group [idcn]
Control Group [grup]
Coagulation [ortf]
Assessed [acty]
Thromboelastography [lbpr]
Sample [sbst]
whole blood [bdsu]
Platelet poor plasma [bdsu]
PPP [dsyn]
Following [tmco]
Thromboelastography [lbpr]
variables [qlco]
Measured [qlco]
Time [tmco]
Initial [tmco]
Coagulation [ortf]
R- [spco]
Blood Clotting [ortf]
Speed [qnco]
K+ [elii, phsu]
Angle [spco]
CLOT [orch, phsu]
tensile strength [qnco]
MA [idcn]
g% [qnco]
Global [spco]
Index [inpr]
Coagulation [ortf]
Fibrinolysis [phsf]
fibrinogen levels [lbpr]
Result [ftcn]
Parameters [fndg]
Compare [acty]
Group [idcn]
fibrinogen levels [lbpr]
Show [inpr]
reduction [npop]
HT [geoa]
Group [idcn]
Increase [ftcn]
Control Group [grup]
months [tmco]
Conclusions [idcn]
Data [idcn]
Suggest [idcn]
transdermal estrogen [horm, phsu, strd]
Not [ftcn]
Increase [ftcn]
Blood [tisu]
fibrinogen levels [lbpr]
Fit [sosy]
Women [popg]
